UnicoCell

Home > News > Press Release

- Press Release
- Events

Press Release

2023-07-10 2023.7.10 Unicocell Biomed Enrolls First Participant in Phase III Clinical Trial for Knee Osteoarthritis
2023-03-31 2023.3.31 Unicocell Biomed Joins Taiwan Extracellular Vesicle Industry-Academia Association as a Member of the STEERING COMMITTEE
2023-03-03 2023.3.3 Unicocell Biomed Knee Osteoarthritis Treatment Receives FDA approval for Phase III Clinical Trial
2023-02-14 2023.2.14 Unicocell Biomed New Drug Receives Certification from SNQ
2023-02-08 2023.2.8 Approval Granted for Unicocell Biomed to Initiate Phase III Clinical Trial for Knee Osteoarthritis Treatment
2022-12-26 2022.12.26 UnicoCell received Acknowledgment letter of DMF (Drug Master File) from US FDA for its allogeneic cell bank
2022-12-03 2022.12.3 UnicoVial was granted the winner at the National Innovation Award Ceremony
2022-11-09 2022.11.9 UnicoVial has won the 19th National Innovation Award held by Institute for Biotechnology and Medicine Industry
2022-09-13 2022.9.13 UnicoCell has submitted an application to US FDA for a Phase III clinical trial of ELIXCYTE
2022-09-01 2022.9.1 UnicoCell has submitted an application to Taiwan FDA for a Phase III clinical trial of ELIXCYTE

«
1
2
3
4
»

2 page / total 4